Bone Biologics
BBLG
7 hedge funds and large institutions have $647K invested in Bone Biologics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
38% more capital invested
Capital invested by funds: $470K → $647K (+$178K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
30% less funds holding
Funds holding: 10 → 7 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$76.4K |
| 2 |
MWA
MFA Wealth Advisors
Pittsburgh,
Pennsylvania
|
+$28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.7K |
| 2 |
Millennium Management
New York
|
-$8.77K |
| 3 |
Walleye Capital
New York
|
-$7.09K |
| 4 |
HF
HRT Financial
New York
|
-$3K |
| 5 |
VF
Virtu Financial
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $388K | +$76.4K | +183 | +21% |
|
|
2
Walleye Capital
New York
| $208K | -$7.09K | -17 | -3% |
|
|
MWA
3
MFA Wealth Advisors
Pittsburgh,
Pennsylvania
| $25K | +$28K | +67 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $11.3K | +$7.93K | +19 | +173% |
|
|
WAM
5
Warberg Asset Management
Winnetka,
Illinois
| $7.75K | – | – | – |
|
|
6
Millennium Management
New York
| $5K | -$8.77K | -21 | -64% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $13 | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10.7K | -36 | Closed |
|
|
HF
10
HRT Financial
New York
| – | -$3K | -12 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$3K | -11 | Closed |
|
|
CAN
12
Cetera Advisor Networks
El Segundo,
California
| – | -$2.2K | -7 | Closed |
|
13
Morgan Stanley
New York
| – | -$2 | – | – |
|
BBLG Hedge Fund Activity: Q1 2023 in Review
7 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics (BBLG) for Q1 2023, worth a combined $647K — up 38% from $470K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BBLG and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, adding an estimated $76.4K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $10.7K sold.
- 7 institutional investors held Bone Biologics (BBLG) as of Q1 2023, down from 10 in Q4 2022.
- Funds reported $647K of Bone Biologics stock for Q1 2023, up 38% quarter-over-quarter.
- 1 fund opened new Bone Biologics positions in Q1 2023 and 4 closed out, a net change of -3 holders.
- The largest Bone Biologics buyer in Q1 2023 was Sabby Management, an estimated $76.4K added.
- The largest Bone Biologics seller in Q1 2023 was Susquehanna International Group, an estimated $10.7K sold.
Based on aggregated 13F filings for Q1 2023.